The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...
Analysts are out in force on Netflix, with shares sliding after the streaming service posted its slowest revenue growth rate ...
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
Seven presentations include pediatric Phase 4 studies of AZSTARYS® (Serdexmethylphenidate/dexmethylphenidate) CII and real-world research of JORNAY PM® (Delayed-Release/Extended-Release Methylphenidat ...
The Christian Post on MSN
5 notable reactions to violent riots roiling France: 'They're destroying that country'
Here are five notable reactions to the chaos in France, which some see as part of a wider assault against a teetering ...
Current Situation and Morning Session OutlookWhile buying interest is likely to emerge in the morning session, the market ...
Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...
"If I write about the same theme as an article with many likes, will it be read?""Are there many likes because there are many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results